EVAXION BIOTECH A S EVAX
ADS · ADR · CUSIP 29970R105
- SectorHealth care
- IndustryBiological Products, (No Diagnostic Substances)
- FilingsSEC EDGAR
8
institutional holders
-3 vs Q1 2021
439.6k
shares reported held*
$3.3mreported value*
2 new
1 added
3 reduced
4 sold out
net sold ≈ $2.7m (-357.7k shares)
* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable. Implied quarter-end price ≈ $7.58.
Trends to Q2 2021
Institutional holders
Managers reporting a position, each quarter
Numbers
| Quarter | Holders |
|---|---|
| Q1 2021 | 11 |
| Q2 2021 | 8 |
Biggest buyers
| Maven Securities LTD | Added | +5.0k |
| UBS Group AG | New | +1.8k |
| SALEM INVESTMENT COUNSELORS INC | New | +5 |
Biggest sellers
| LUMINUS MANAGEMENT LLC | Sold out | -194.9k |
| Granite Point Capital Management, L.P. | Reduced | -106.9k |
| Telemetry Investments, L.L.C. | Reduced | -32.1k |
| Altium Capital Management LLC | Sold out | -24.7k |
| OSAIC HOLDINGS, INC. | Sold out | -5.4k |
| ETF MANAGERS GROUP, LLC | Reduced | -256 |
| MORGAN STANLEY | Sold out | -100 |
Insider purchases and sales in Q2 2021
Shares bought or sold by the company's own officers, directors and 10% owners, in the open market or privately, as they reported to the SEC on Form 4 (due within two business days of the trade). Grants, option exercises, shares withheld for tax and gifts aren't included.
None reported in Q2 2021.
Holders, Q2 2021
| Manager | Shares | Change |
|---|---|---|
| Maven Securities LTD 0.19% of their portfolio | 235.6k $1.8m | Added +5.0k |
| Granite Point Capital Management, L.P. 0.27% of their portfolio | 117.7k $911.0k | Reduced -106.9k |
| Telemetry Investments, L.L.C. 0.44% of their portfolio | 41.7k $315.0k | Reduced -32.1k |
| Kepos Capital LP 0.02% of their portfolio | 37.1k $287.0k | Unchanged |
| ETF MANAGERS GROUP, LLC 0.00% of their portfolio | 5.7k $43.0k | Reduced -256 |
| UBS Group AG 0.00% of their portfolio | 1.8k $14.0k | New |
| SALEM INVESTMENT COUNSELORS INC 0.00% of their portfolio | 5 $0 | New |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0.00% of their portfolio | 0 $0 | Unchanged |